Macitentan in incident and prevalent pulmonary arterial hypertension (PAH): OPUS/OrPHeUS real-world data

被引:0
|
作者
Melendres-Groves, Lana [1 ]
Channick, Richard [2 ]
Chin, Kelly [3 ]
Mclaughlin, Vallerie V. [4 ]
Flynn, Megan [5 ]
Ong, Rose [6 ]
Wetherill, Graham [6 ]
Kim, Nick H. [7 ]
机构
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] UT Southwestern Med Ctr, Dallas, TX USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Actelion Pharmaceut US Inc, San Francisco, CA USA
[6] Actelion Pharmaceut Ltd, Allschwil, Switzerland
[7] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
Chronic diseases; Treatments; Pulmonary hypertension;
D O I
10.1183/13993003.congress-2020.1463
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
1463
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies
    Chin, Kelly M.
    Channick, Richard
    Kim, Nick H.
    Macdonald, Gwen
    Ong, Rose
    Martin, Nicolas
    Senatore, Assunta
    McLaughlin, Vallerie V.
    ADVANCES IN THERAPY, 2024, 41 (11) : 4205 - 4227
  • [2] Real-World Upfront Combination Therapy with Macitentan and Tadalafil in Pulmonary Arterial Hypertension (PAH): Data from the Combined OPUS and OrPHeUS Datasets
    Chin, K. M.
    Channick, R.
    McLaughlin, V. V.
    Melendres-Groves, L.
    Flynn, M.
    Leroy, S.
    Wetherill, G.
    Kim, N. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] Macitentan in pulmonary hypertension (PH): Data from OPUS and OrPHeUS real-world data sets
    Kim, Nick
    Channick, Richard
    Chin, Kelly
    Melendres-Groves, Lana
    Ravichandran, Ashwin
    Brand, Monika
    Flynn, Megan
    Leroy, Sandrine
    Morganti, Adele
    Mclaughlin, Vallerie
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS
    Channick, R.
    Chin, K. M.
    Kim, N. H.
    Ong, R.
    Turricchia, S.
    Mitchell, L.
    McLaughlin, V. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1916 - 1916
  • [5] Macitentan in portopulmonary hypertension (PoPH): Real-world data from OPUS and OrPHeUS
    Kim, Nick
    Chin, Kelly
    Mclaughlin, Vallerie
    Restrepo-Jaramillo, Ricardo
    Safdar, Zeenat
    Brand, Monika
    Flynn, Megan
    Leroy, Sandrine
    Morganti, Adele
    Channick, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [6] Treatment with macitentan for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): real-world experience from the combined OPUS and OrPHeUS data sets
    McLaughlin, V
    Chin, K.
    Kim, N. H.
    Flynn, M.
    Ong, R.
    Wetherill, G.
    Channick, R.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2293 - 2293
  • [7] Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies
    Chin, Kelly M.
    Channick, Richard
    Kim, Nick H.
    Ong, Rose
    Turricchia, Stefano
    Martin, Nicolas
    Mitchell, Lada
    Mclaughlin, Vallerie V.
    CARDIOLOGY AND THERAPY, 2024, 13 (04) : 775 - 796
  • [8] MACITENTAN IN PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE: REAL-WORLD EVIDENCE FROM THE COMBINED OPUS/ORPHEUS DATA SETS
    McLaughlin, Vallerie
    Channick, Richard
    Kim, Nick
    Lammi, Matthew
    Sulica, Roxana
    Brand, Monika
    Flynn, Megan
    Leroy, Sandrine
    Morganti, Adele
    Chin, Kelly
    CHEST, 2019, 156 (04) : 874A - 876A
  • [9] Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset
    Channick, Richard
    Chin, Kelly M.
    Mclaughlin, Vallerie V.
    Lammi, Matthew R.
    Zamanian, Roham T.
    Turricchia, Stefano
    Ong, Rose
    Mitchell, Lada
    Kim, Nick H.
    CARDIOLOGY AND THERAPY, 2024, 13 (02) : 315 - 339
  • [10] Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset
    Richard Channick
    Kelly M. Chin
    Vallerie V. McLaughlin
    Matthew R. Lammi
    Roham T. Zamanian
    Stefano Turricchia
    Rose Ong
    Lada Mitchell
    Nick H. Kim
    Cardiology and Therapy, 2024, 13 : 315 - 339